Allan Jonathan
SEC CIK 1966716 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | GC, Corp Sec | 21.2K | — | $2.82M | 30 | 2023-06-21 | 2026-08-18 |
Most active insiders at STOK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krainer Adrian R. | Dir | — | $3.90M |
| 2 | Kaye Edward M. MD | Dir | — | $3.18M |
| 3 | Ticho Barry | Chief MEDICAL Off | — | $1.98M |
| 4 | Allan Jonathan | GC, CORP SEC | — | $1.56M |
| 5 | TZIANABOS ARTHUR | Interim Executive COB, Dir | — | $174.2K |
| 6 | Leggett Thomas | CFO | — | $147.1K |
| 7 | Hoitt Jason | Chief Patient Off | — | $119.3K |
| 8 | LEVIN ARTHUR A | Dir | — | $22.3K |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 20:27 | 2026-08-14 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +6,000 | 24.1K | +33% | $0 |
| DM | 2026-08-18 20:27 | 2026-08-18 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $32.03 | -2,861 | 21.2K | -12% | -$91.6K |
| T | 2026-06-18 16:18 | 2026-06-16 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $29.95 | -1,457 | 18.1K | -7% | -$43.6K |
| M | 2026-03-24 | 2026-03-20 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $33.69 | -9,293 | 19.5K | -32% | -$313.1K |
| M | 2026-03-19 | 2026-03-17+ | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $32.14 | -8,895 | 28.9K | -24% | -$285.9K |
| DM | 2026-03-17 | 2026-03-15 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +25.5K | 19.7K | New | $0 |
| M | 2025-12-10 | 2025-12-08 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $32.28 | -3,978 | 14.5K | -22% | -$128.4K |
| D | 2025-12-05 | 2025-12-03 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +6,000 | 25.6K | +31% | $0 |
| DM | 2025-12-05 | 2025-12-04+ | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $31.25 | -9,803 | 24.6K | -28% | -$306.3K |
| DM | 2025-12-03 | 2025-12-02+ | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $30.22 | -4,576 | 22.8K | -17% | -$138.3K |
| D | 2025-12-03 | 2025-12-01 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +12.4K | 24.2K | +104% | $0 |
| D | 2025-10-07 | 2025-10-03 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $9.15 | +10.0K | 21.8K | +85% | +$91.5K |
| D | 2025-10-07 | 2025-10-03 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $25.07 | -10.0K | 11.8K | -46% | -$250.7K |
| DM | 2025-09-03 | 2025-08-29+ | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $7.07 | +10.0K | 33.1K | +43% | +$70.7K |
| DM | 2025-09-03 | 2025-08-29+ | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $20.11 | -22.1K | 18.2K | -55% | -$444.9K |
| 2025-08-20 | 2025-08-18 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $18.24 | -1,683 | 23.9K | -7% | -$30.7K | |
| D | 2025-08-18 | 2025-08-14 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +6,000 | 25.6K | +31% | $0 |
| 2025-08-15 | 2025-08-13 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $15.00 | -13.7K | 19.6K | -41% | -$205.7K | |
| DM | 2025-03-20 | 2025-03-18+ | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $8.49 | -4,211 | 33.5K | -11% | -$35.7K |
| DM | 2025-03-18 | 2025-03-15 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +13.5K | 29.8K | +83% | $0 |
| M | 2024-12-11 | 2024-12-09 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $13.61 | -13.7K | 23.0K | -37% | -$186.0K |
| 2024-12-10 | 2024-12-06 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $12.78 | -9,696 | 35.1K | -22% | -$123.9K | |
| D | 2024-12-05 | 2024-12-03 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +6,000 | 44.8K | +15% | $0 |
| D | 2024-12-03 | 2024-12-01 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +33.9K | 38.8K | +691% | $0 |
| D | 2024-05-22 | 2024-05-20 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $7.07 | +8,599 | 11.2K | +331% | +$60.8K |
| D | 2024-05-22 | 2024-05-20 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $15.04 | -8,599 | 2,598 | -77% | -$129.3K |
| M | 2024-04-01 | 2024-03-28 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale | $13.20 | -5,126 | 2,598 | -66% | -$67.7K |
| D | 2024-03-19 | 2024-03-15 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +7,475 | 10.1K | +288% | $0 |
| D | 2024-03-19 | 2024-03-19 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, CORP SEC | S - Sale+OE | $6.10 | -2,349 | 7,724 | -23% | -$14.3K |
| 2023-06-23 | 2023-06-21 | STOK | Stoke Therapeutics, Inc. | Allan Jonathan | GC, Corp Sec | S - Sale | $13.48 | -1,948 | 0 | -100% | -$26.3K |
Purchase Sale Sale after option exercise All abbreviations